0001181158-11-000003.txt : 20110519 0001181158-11-000003.hdr.sgml : 20110519 20110519153636 ACCESSION NUMBER: 0001181158-11-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110518 FILED AS OF DATE: 20110519 DATE AS OF CHANGE: 20110519 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MAGNUSON TERRY CENTRAL INDEX KEY: 0001181158 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27570 FILM NUMBER: 11857809 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACEUTICAL PRODUCT DEVELOPMENT INC CENTRAL INDEX KEY: 0001003124 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 561640186 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2011-05-18 0001003124 PHARMACEUTICAL PRODUCT DEVELOPMENT INC PPDI 0001181158 MAGNUSON TERRY 408 BAYBERRY DRIVE CHAPEL HILL NC 27514 1 0 0 0 Common Stock 2011-05-18 4 A 0 1139 0 A 17633 D Stock Options (to buy) 28.52 2011-05-18 4 A 0 9095 0 A 2011-05-18 2021-05-18 Common Stock 9095 9095 D Stock Options (to buy) 24.26 2011-07-30 2020-07-30 9090 9090 9090 D Stock Options (to buy) 24.52 2010-05-20 2020-05-20 Common Stock 10496 10496 D Stock Options (to buy) 19.19 2009-05-20 2019-05-20 Common Stock 14053 14053 D Stock Options (to buy) 41.32 2008-05-21 2018-05-20 Common Stock 6485 6485 D Stock Options (to buy) 32.67 2007-05-16 2017-05-15 Common Stock 6341 6341 D Stock Options (to buy) 12.37 2002-05-15 2012-05-14 Common Stock 12421 12421 D Stock Options (to buy) 13.12 2003-05-14 2013-05-13 Common Stock 16561 16561 D Stock Options (to buy) 15.28 2004-05-19 2014-05-18 Common Stock 16561 16561 D Stock Options (to buy) 22.98 2005-05-18 2015-05-17 Common Stock 5650 5650 D Stock Options (to buy) 34.18 2006-05-17 2016-05-16 Common Stock 4113 4113 D Direct Holdings include an anti-dilution adjustment of 295 shares to restricted stock held made in connection with the June 14, 2010 spin-off of Furiex Pharmaceuticals, Inc. The options vest in three equal increments on 7/30/2011, 7/30/2012 and 7/30/2013. Lisa C. Noecker attorney-in-fact for Terry Magnuson 2011-05-19